Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Isis Pharmaceuticals, Inc.
(NQ:
ISIS
)
22.58
USD
-0.50 (-2.17%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
23.03
Bid (Size)
22.58 (1900)
Ask (Size)
22.59 (1600)
Prev. Close
23.08
Today's Range
22.45 - 23.03
52wk Range
7.555 - 24.04
Shares Outstanding
113,398,290
Dividend Yield
N/A
Top News
More News
Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics
June 18, 2013
Editor Note: For more information about this release, please scroll to bottom.
Read More
from
PR Newswire
Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
June 18, 2013
from
PR Newswire
More News
Read More
For Love and Money: Three Growth Stocks from Casey’s Alex Daley
June 13, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Stocks Hitting 52-Week Highs
June 12, 2013
category
RMBS
,
Benzinga
,
WINA
, and 7 more.
from
Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 6/11/2013
June 11, 2013
category
SLXP
,
QCOR
,
FRX
, and 5 more.
from
Bio-Wire.Com
Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
June 10, 2013
from
PR Newswire
Miss ISIS's $19 Secondary But Think It's A Steal At $12?
June 07, 2013
category
Dividends
from
Dividend Channel
Miss ISIS's $19 Secondary But Think It's A Steal At $12?
June 07, 2013
category
Stocks
from
Market News Video
Isis Pharma (ISIS) Receives $6M from AstraZeneca (AZN) in Research Collaboration
June 06, 2013
from
StreetInsider.com News Articles
Isis Pharma Announces $6M Payment from AstraZeneca
June 06, 2013
category
Benzinga
,
News
,
ISIS
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.